U.S. CDC recommends re-isolation if COVID recurs after taking Pfizer's pill - Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/O25QFWJE3BOIDOVHNNKU4QHQXM.jpg)
5/24/2022 12:00:00 AM2 years 11 months ago
Patients who experience recurrence of COVID-19 symptoms after completing treatment with Pfizer's <a href="https://www.reuters.com/companies/PFE.N" target="_blank">(PFE.N)</a> drug Paxlovid should isolate again for five days, the U.S. Centers for Disease Contr…
May 24 (Reuters) - Patients who experience recurrence of COVID-19 symptoms after completing treatment with Pfizer's (PFE.N) drug Paxlovid should isolate again for five days, the U.S. Centers for Dise… [+1205 chars]
full article...